Dana Cohen is a senior manager with vast experience in the private and public biotech industry. Currently she is the CEO of DiagKnowstics and also the head of personalized & predictive medicine at ZOTAL.
Prior to that she was the founder, inventor and CEO of BioMarCare Technologies (Companion Diagnostics) , CEO of TKsignal (pioneering development of radioactive biomarkers for PET/SPECT cancer imaging) and a marketing manager at Pronto Diagnostics (development of IVD kits for the diagnosis of genetic diseases).  

Sigalit is a senior manager with more than 25 years of experience in the world of health, pharma, and Diagnostics.
She has a proven background in initiating and leading business operations of well-known global companies, from the strategy phase to the launch phase, including achieving significant growth targets.
Sigalit has extensive experience in identifying and implementing new ideas and work plans for penetrating new markets, while identifying risks and building a set of solutions.